- Global Pharma, Biotech and Diagnostics Asset Purchase Partnering Terms and Agreements Report 2021
- Recro Announces Proposed Public Offering of Common Stock
- U.S. Medical Cannabis Market Projected to Almost Double to Over $16 Billion by 2025
- Catalyst Pharmaceuticals Announces First Quarter 2021 Financial Results and Provides Business Update
- AquaBounty Sells Out the First Commercial-Scale Harvest of Genetically Engineered Atlantic Salmon from its Indiana Farm
- Cytokinetics Announces Three Upcoming Presentations Related to Heart Failure and Hypertrophic Cardiomyopathy at American College of Cardiology 70th Annual Scientific Session
- Gastrointestinal Drugs Market Growth Sturdy at 4.9% CAGR to Outstrip $71,300.28 Million by 2027 - COVID-19 Impact and Global Analysis by TheInsightPartners.com
- Cryo-Cell International Proudly Announces Two Ongoing COVID-19 Related Trials
- Adverum Issues Statement Regarding Upcoming Annual Meeting of Stockholders
- Onconova Therapeutics to Provide Corporate Update and Announce First Quarter 2021 Financial Results on May 17, 2021
